Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular CarcinomaMasahito Nakano, Nobuyoshi Tajiri, Norito Matsukuma et al.|Oncology|2012Cited by 34
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular CarcinomaHideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu et al.|Cancers|2021Cited by 32
Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II studyHiroaki Nagamatsu, Takuji Torimura, Shuji Sumie et al.|Cancer Chemotherapy and Pharmacology|2016Cited by 28
First‐line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective studyShigeo Shimose, Takuji Torimura, Atsushi Hiraoka et al.|Cancer Medicine|2021Cited by 16